Related Articles
Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibition
Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib
MicroRNA‑181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib
Homoharringtonine enhances the effect of imatinib on chronic myelogenous leukemia cells by downregulating ZFX
TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β‑catenin/TCF7/ABC transporter signaling axis